Sung Jun Park
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sung Jun Park has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
- Joon Bum Kim
Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, Seoul, Korea
6 shared publications - Ho Jin Kim
Division of Cardiac Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
3 shared publications - Jae Won Lee
Department of Thoracic and Cardiovascular Surgery, Armed Forces Capital Hospital, Seongnam, Korea
3 shared publications - Suk Jung Choo
Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
3 shared publications - Sung-Ho Jung
Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
3 shared publications - Young-Nam Youn
Division of Cardiovascular Surgery, Department of Thoracic and Cardiovascular Surgery, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea
3 shared publications
Latest Publications
- 12 November 2026
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
Sex-Specific Molecular Patterns Reveal Distinct Age-Associated Arterial Wall Remodeling
BACKGROUND: Coronary artery disease is highly prevalent among elderly patients and often requires revascularization through coronary artery bypass grafting. Women typically undergo coronary artery bypass grafting at older ages than men and experience worse outcomes, disparities that persist even after adjustment for age and clinical variables, suggesting that elderly women face unique biological vulnerabilities not captured by traditional risk factors. This study investigated sex-specific molecular patterns associated with distinct age-associated arterial wall remodeling in patients with coronary artery disease. METHODS: In this cross-sectional study, internal thoracic artery specimens were obtained between July 2022 and August 2023 from 135 patients undergoing coronary artery bypass grafting (88 males and 47 females; mean age, 66.3 years). Patients were stratified by age (P =0.017). Transcriptomic profiling revealed age-associated enrichment of lipid metabolism–related pathways, with upregulation of ADIPOQ , LPL , and FABP4 in elderly patients of both sexes. Divergent molecular patterns were identified beyond this shared age-associated profile. Males showed a proliferative pattern associated with immune suppression and lower EGR1 expression, whereas females exhibited a pattern consistent with impaired structural integrity, accompanied by upregulation of stress-response genes ( JUN and JUNB ) and reduced expression of the extracellular matrix gene FN1 . CONCLUSIONS: Internal thoracic arteries from elderly patients with coronary artery disease exhibit distinct sex-specific arterial wall remodeling patterns, with immune-suppressed proliferative remodeling in males and stress-associated extracellular matrix vulnerability in females. These findings provide a biological framework for understanding sex differences in age-associated arterial remodeling and may provide context for sex disparities in cardiovascular outcomes.
- 12 November 2026
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
Sex-Specific Molecular Patterns Reveal Distinct Age-Associated Arterial Wall Remodeling
BACKGROUND: Coronary artery disease is highly prevalent among elderly patients and often requires revascularization through coronary artery bypass grafting. Women typically undergo coronary artery bypass grafting at older ages than men and experience worse outcomes, disparities that persist even after adjustment for age and clinical variables, suggesting that elderly women face unique biological vulnerabilities not captured by traditional risk factors. This study investigated sex-specific molecular patterns associated with distinct age-associated arterial wall remodeling in patients with coronary artery disease. METHODS: In this cross-sectional study, internal thoracic artery specimens were obtained between July 2022 and August 2023 from 135 patients undergoing coronary artery bypass grafting (88 males and 47 females; mean age, 66.3 years). Patients were stratified by age (P =0.017). Transcriptomic profiling revealed age-associated enrichment of lipid metabolism–related pathways, with upregulation of ADIPOQ , LPL , and FABP4 in elderly patients of both sexes. Divergent molecular patterns were identified beyond this shared age-associated profile. Males showed a proliferative pattern associated with immune suppression and lower EGR1 expression, whereas females exhibited a pattern consistent with impaired structural integrity, accompanied by upregulation of stress-response genes ( JUN and JUNB ) and reduced expression of the extracellular matrix gene FN1 . CONCLUSIONS: Internal thoracic arteries from elderly patients with coronary artery disease exhibit distinct sex-specific arterial wall remodeling patterns, with immune-suppressed proliferative remodeling in males and stress-associated extracellular matrix vulnerability in females. These findings provide a biological framework for understanding sex differences in age-associated arterial remodeling and may provide context for sex disparities in cardiovascular outcomes.
- Open Access
- 15 September 2026
- Published by Elsevier in JTCVS Open
Impact of inflow source and target vessel stenosis on saphenous vein graft after coronary artery bypass: Aortocoronary versus composite graft
- 15 September 2026
- Published by Elsevier in JTCVS Open
Open AccessImpact of inflow source and target vessel stenosis on saphenous vein graft after coronary artery bypass: Aortocoronary versus composite graft
- Open Access
- 1 January 2026
- Published by XMLink in Journal of Korean Medical Science
- Vol. 41 (27) , e207
Impact of Kidney Function on the Treatment Effect of Multi-Arterial Grafting in CABG Patients
Park SJ, et al. J Korean Med Sci. 2026 Jul;41:e207. https://doi.org/10.3346/jkms.2026.41.e207
- 1 January 2026
- Published by XMLink in Journal of Korean Medical Science
- Vol. 41 (27) , e207
Open AccessImpact of Kidney Function on the Treatment Effect of Multi-Arterial Grafting in CABG Patients
Park SJ, et al. J Korean Med Sci. 2026 Jul;41:e207. https://doi.org/10.3346/jkms.2026.41.e207
- Open Access
- 1 January 2026
- Published by XMLink in Korean Circulation Journal
- Vol. 56 (2) , 160-174
Single Versus Multiple Inflow Source for Coronary Artery Bypass Surgery in Ischemic Cardiomyopathy
Park SJ, et al. Korean Circ J. 2025 Aug;56:e6. https://doi.org/10.4070/kcj.2025.0103
- 1 January 2026
- Published by XMLink in Korean Circulation Journal
- Vol. 56 (2) , 160-174
Open AccessSingle Versus Multiple Inflow Source for Coronary Artery Bypass Surgery in Ischemic Cardiomyopathy
Park SJ, et al. Korean Circ J. 2025 Aug;56:e6. https://doi.org/10.4070/kcj.2025.0103
- Open Access
- 5 November 2023
- Published by Korean Society for Thoracic and Cardiovascular Surgery in Journal of Chest Surgery
- Vol. 56 (6) , 371-373
In Memoriam: Suk Jung Choo (1964–2023)
Ho Jin Kim, M.D., Hong Rae Kim, M.D., Sung Jun Park, M.D., Joon Bum Kim, M.D., Ph.D.. J Chest Surg 2023;56:371-3. https://doi.org/10.5090/jcs.23.148
- 5 November 2023
- Published by Korean Society for Thoracic and Cardiovascular Surgery in Journal of Chest Surgery
- Vol. 56 (6) , 371-373
Open AccessIn Memoriam: Suk Jung Choo (1964–2023)
Ho Jin Kim, M.D., Hong Rae Kim, M.D., Sung Jun Park, M.D., Joon Bum Kim, M.D., Ph.D.. J Chest Surg 2023;56:371-3. https://doi.org/10.5090/jcs.23.148
- Open Access
- 23 February 2022
- Published by Korean Society for Thoracic and Cardiovascular Surgery in Journal of Chest Surgery
- Vol. 55 (2) , 180-182
Left Ventricular Enlargement Procedure in a Patient with Diffuse-Type Hypertrophic Cardiomyopathy: A Case Report
Dong Youb Han, M.D., Sung Jun Park, M.D., Sung-Ho Jung, M.D., Ph.D.. J Chest Surg 2022;55:180-2. https://doi.org/10.5090/jcs.21.114
- 23 February 2022
- Published by Korean Society for Thoracic and Cardiovascular Surgery in Journal of Chest Surgery
- Vol. 55 (2) , 180-182
Open AccessLeft Ventricular Enlargement Procedure in a Patient with Diffuse-Type Hypertrophic Cardiomyopathy: A Case Report
Dong Youb Han, M.D., Sung Jun Park, M.D., Sung-Ho Jung, M.D., Ph.D.. J Chest Surg 2022;55:180-2. https://doi.org/10.5090/jcs.21.114
- Open Access
- 5 February 2022
- Published by Korean Society for Thoracic and Cardiovascular Surgery in Journal of Chest Surgery
- Vol. 55 (1) , 69-76
Bioprosthesis in the Mitral Position: Bovine Pericardial versus Porcine Xenograft
Dong Youb Han, M.D., Sung Jun Park, M.D., Ho Jin Kim, M.D., Sung-Ho Jung, M.D., Ph.D., Suk Jung Choo, M.D., Ph.D., Cheol Hyun Chung, M.D., Ph.D., Jae Won Lee, M.D., Ph.D., Joon Bum Kim, M.D., Ph.D.. J Chest Surg 2022;55:69-76. https://doi.org/10.5090/jcs.21.103
- 5 February 2022
- Published by Korean Society for Thoracic and Cardiovascular Surgery in Journal of Chest Surgery
- Vol. 55 (1) , 69-76
Open AccessBioprosthesis in the Mitral Position: Bovine Pericardial versus Porcine Xenograft
Dong Youb Han, M.D., Sung Jun Park, M.D., Ho Jin Kim, M.D., Sung-Ho Jung, M.D., Ph.D., Suk Jung Choo, M.D., Ph.D., Cheol Hyun Chung, M.D., Ph.D., Jae Won Lee, M.D., Ph.D., Joon Bum Kim, M.D., Ph.D.. J Chest Surg 2022;55:69-76. https://doi.org/10.5090/jcs.21.103
- 26 July 2021
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 36 (10) , 3711-3718
Comparison of dopamine versus norepinephrine in circulatory shock after cardiac surgery: A randomized controlled trial
Background and Aim of the Study Although dopamine and norepinephrine are recommended as first-line agents in the treatment of shock, it is unclear which is the optimal vasoactive inotropic agent (VIA) to manage postcardiotomy circulatory shock. This single-center, randomized clinical trial aimed to investigate the efficacy and safety of dopamine versus norepinephrine in postcardiotomy circulatory shock. Methods We randomly assigned the patients with postcardiotomy circulatory shock to receive either dopamine or norepinephrine. When shock persisted despite the dose of 20 μg/kg/min of dopamine or the dose of 0.2 μg/kg/min of norepinephrine, epinephrine or vasopressin could be added. The primary endpoint was new-onset tachyarrhythmic event during drug infusion. Secondary endpoints included requirement of additional VIAs, postoperative complications, and all-cause mortality within 30 days of drug initiation. Results At the planned interim analysis of 100 patients, the boundary for the benefit of norepinephrine has been crossed, and the study was stopped early. Excluding two patients withdrawing a consent, 48 patients were assigned to dopamine and 50 patients to norepinephrine. New-onset tachyarrhythmic event occurred in 12 (25%) patients in the dopamine and one (2%) patient in the norepinephrine group (p = .009). The requirement for additional VIAs was more common in the dopamine group (p < .001). Other secondary endpoints were similar between groups. Conclusions Despite the limited study subjects with early determination, in patients with postcardiotomy circulatory shock, dopamine as a first-line vasopressor was associated with higher tachyarrhythmic events and greater need for additional VIAs compared with norepinephrine.
- 26 July 2021
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 36 (10) , 3711-3718
Comparison of dopamine versus norepinephrine in circulatory shock after cardiac surgery: A randomized controlled trial
Background and Aim of the Study Although dopamine and norepinephrine are recommended as first-line agents in the treatment of shock, it is unclear which is the optimal vasoactive inotropic agent (VIA) to manage postcardiotomy circulatory shock. This single-center, randomized clinical trial aimed to investigate the efficacy and safety of dopamine versus norepinephrine in postcardiotomy circulatory shock. Methods We randomly assigned the patients with postcardiotomy circulatory shock to receive either dopamine or norepinephrine. When shock persisted despite the dose of 20 μg/kg/min of dopamine or the dose of 0.2 μg/kg/min of norepinephrine, epinephrine or vasopressin could be added. The primary endpoint was new-onset tachyarrhythmic event during drug infusion. Secondary endpoints included requirement of additional VIAs, postoperative complications, and all-cause mortality within 30 days of drug initiation. Results At the planned interim analysis of 100 patients, the boundary for the benefit of norepinephrine has been crossed, and the study was stopped early. Excluding two patients withdrawing a consent, 48 patients were assigned to dopamine and 50 patients to norepinephrine. New-onset tachyarrhythmic event occurred in 12 (25%) patients in the dopamine and one (2%) patient in the norepinephrine group (p = .009). The requirement for additional VIAs was more common in the dopamine group (p < .001). Other secondary endpoints were similar between groups. Conclusions Despite the limited study subjects with early determination, in patients with postcardiotomy circulatory shock, dopamine as a first-line vasopressor was associated with higher tachyarrhythmic events and greater need for additional VIAs compared with norepinephrine.
- Open Access
- 25 June 2021
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 36 (9) , 3283-3287
Videoscope‐assisted transaortic myectomy in patients with hypertrophic cardiomyopathy with complex left ventricular anatomy
Background The transaortic approach is the most common method of septal myectomy. However, difficulties arise due to a limited view of the surgical field. Here, we report our experience with videoscope-assisted transaortic myectomy. Methods We reviewed myectomy operations that were performed between July 2015 and June 2019 at Chung-Ang University Hospital, Seoul, South Korea. Patients who previously had cardiac surgery, alcohol septal ablation, or concomitant disease which required combined surgery, were excluded. Among the 21 patients included, 10 patients underwent videoscope-assisted transaortic myectomy (VA group), and 11 patients underwent myectomy in a conventional manner (CO group). The preoperative data, echocardiographic images, operative records, and postoperative outcomes of these patients were reviewed. Results There were no differences in baseline characteristics between groups VA and CO. The main indications for videoscope-assisted transaortic myectomy in group VA were midventricular septal muscle resection (70%), abnormal papillary muscle resection (40%), and abnormal chordal connection resection (30%). Eight (80%) patients had multiple indications for videoscope-assisted transaortic myectomy. There was no surgical mortality in either group. Postoperative patients showed less than moderate mitral regurgitation and a New York Heart Association class either III or IV. There were no differences in hospital days (9.5 vs. 12.0 days; p = .383), nor postoperative pressure gradient (14 vs. 15 mmHg; p > .99). Conclusions Videoscope-assisted transaortic myectomy is an effective surgical technique in selective hypertrophic cardiomyopathy patients with complex intraventricular anatomy, diffuse hypertrophy, and midventricular obstruction.
- 25 June 2021
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 36 (9) , 3283-3287
Open AccessVideoscope‐assisted transaortic myectomy in patients with hypertrophic cardiomyopathy with complex left ventricular anatomy
Background The transaortic approach is the most common method of septal myectomy. However, difficulties arise due to a limited view of the surgical field. Here, we report our experience with videoscope-assisted transaortic myectomy. Methods We reviewed myectomy operations that were performed between July 2015 and June 2019 at Chung-Ang University Hospital, Seoul, South Korea. Patients who previously had cardiac surgery, alcohol septal ablation, or concomitant disease which required combined surgery, were excluded. Among the 21 patients included, 10 patients underwent videoscope-assisted transaortic myectomy (VA group), and 11 patients underwent myectomy in a conventional manner (CO group). The preoperative data, echocardiographic images, operative records, and postoperative outcomes of these patients were reviewed. Results There were no differences in baseline characteristics between groups VA and CO. The main indications for videoscope-assisted transaortic myectomy in group VA were midventricular septal muscle resection (70%), abnormal papillary muscle resection (40%), and abnormal chordal connection resection (30%). Eight (80%) patients had multiple indications for videoscope-assisted transaortic myectomy. There was no surgical mortality in either group. Postoperative patients showed less than moderate mitral regurgitation and a New York Heart Association class either III or IV. There were no differences in hospital days (9.5 vs. 12.0 days; p = .383), nor postoperative pressure gradient (14 vs. 15 mmHg; p > .99). Conclusions Videoscope-assisted transaortic myectomy is an effective surgical technique in selective hypertrophic cardiomyopathy patients with complex intraventricular anatomy, diffuse hypertrophy, and midventricular obstruction.
- Open Access
- 11 November 2020
- Published by Korean Society for Thoracic and Cardiovascular Surgery in The Korean Journal of Thoracic and Cardiovascular Surgery
- Vol. 53 (6) , 346-352
Surgical Outcomes of Kommerell Diverticulum
Young Kern Kwon, M.D., Sung Jun Park, M.D., Suk Jung Choo, M.D., Ph.D., Tae Jin Yun, M.D., Ph.D., Jae Won Lee, M.D., Ph.D., Joon Bum Kim, M.D., Ph.D.. Korean J Thorac Cardiovasc Surg 2020;53:346-52. https://doi.org/10.5090/kjtcs.20.071
- 11 November 2020
- Published by Korean Society for Thoracic and Cardiovascular Surgery in The Korean Journal of Thoracic and Cardiovascular Surgery
- Vol. 53 (6) , 346-352
Open AccessSurgical Outcomes of Kommerell Diverticulum
Young Kern Kwon, M.D., Sung Jun Park, M.D., Suk Jung Choo, M.D., Ph.D., Tae Jin Yun, M.D., Ph.D., Jae Won Lee, M.D., Ph.D., Joon Bum Kim, M.D., Ph.D.. Korean J Thorac Cardiovasc Surg 2020;53:346-52. https://doi.org/10.5090/kjtcs.20.071